First human myoblast transfer therapy continues to show dystrophin after 6 years.
Law
P K
PK
Cell Therapy Research Foundation, Memphis, TN 38117, USA.
Goodwin
T G
TG
Fang
Q
Q
Hall
T L
TL
Quinley
T
T
Vastagh
G
G
Duggirala
V
V
Larkin
C
C
Florendo
J A
JA
Li
L
L
Jackson
T
T
Yoo
T J
TJ
Chase
N
N
Neel
M
M
Krahn
T
T
Holcomb
R
R
D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D016189:Dystrophin / Q000032:analysis*; D005500:Follow-Up Studies; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009132:Muscles / Q000166:cytology / Q000637:transplantation*; D009136:Muscular Dystrophies / Q000628:therapy*
D016189:Dystrophin; D016572:Cyclosporine